EVALUATION OF THE USE OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN CHILDREN AND ADOLESCENTS WITH CONGENITAL HEART DISEASE: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61164/rmnm.v12i3.3138Keywords:
Cardioversor Desfibrilador Implantável; Cardiopatia Congênita; Crianças; Adolescentes; Revisão Sistemática.Abstract
Sudden Cardiac Death can be one of the first manifestations of congenital heart diseases in children and adolescents; thus, early diagnosis and appropriate intervention are of utmost importance. In this context, this systematic review aims to evaluate the outcomes of using implantable cardioverter-defibrillators (ICDs) in children and adolescents with congenital heart diseases from January 2018 to June 2023, clarifying their complications and elucidating the results obtained in recent studies to contribute to medical knowledge. This research was conducted through the databases PubMed, Lilacs, and Scielo, selecting articles that assessed the use of ICDs in children and adolescents with congenital heart diseases. Out of an initial 379 studies, 14 were included in the final analysis. A total of 650 patients were analyzed, with 376 males and 274 females. The cardiac diseases were categorized into three groups: Primary Electrical Disease, Congenital Heart Disease, and Cardiomyopathies. Complications occurred in 134 patients (20.58%), appropriate shocks in 155 (23.81%), and inappropriate shocks in 120 patients (18.54%). The average age of the patients assessed was 14.03 years, the average follow-up time was 66.4 months, and the mortality rate in this population was 2.15%.
Downloads
References
REFERÊNCIAS
Ailes EC, Gilboa SM, Riehle-Colarusso T, Johnson CY, Hobbs CA, Correa A, et al. Prenatal diagnosis of nonsyndromic congenital heart defects. Prenat Diagn. 2014 Mar;34(3):214–22. DOI: https://doi.org/10.1002/pd.4282
Rella V, Parati G, Crotti L. Sudden Cardiac Death in Children Affected by Cardiomyopathies: An Update on Risk Factors and Indications at Transvenous or Subcutaneous Implantable Defibrillators. Vol. 8, Frontiers in Pediatrics. Frontiers Media S.A.; 2020. DOI: https://doi.org/10.3389/fped.2020.00139
Miller JD, Yousuf O, Berger RD. The implantable cardioverter-defibrillator: An update. Vol. 25, Trends in Cardiovascular Medicine. Elsevier Inc.; 2015. p. 606–11. DOI: https://doi.org/10.1016/j.tcm.2015.01.015
Mori H, Sumitomo N, Tsutsui K, Fukunaga H, Hayashi H, Nakajima H, et al. Efficacy of SubcutAneous implantable cardioVErter-defibrillators in ≤18 year-old CHILDREN: SAVE-CHILDREN registry. Int J Cardiol. 2023 Jan 15;371:204–10. DOI: https://doi.org/10.1016/j.ijcard.2022.09.008
Koury A, Jurubeba X, Saleh A, Amanda K;, Fraga S, Phillipe J, et al. CAPÍTULO 6 ETIOLOGIA, POSSÍVEIS FATORES DE RISCOS E ASPECTOS RELACIONADOS À IDENTIFICAÇÃO E PREVENÇÃO DA MORTE SÚBITA CARDÍACA.
Pitak MJ, Jastrzębski M, Rudek-Budzyńska A, Weryński P, Winter J, Góreczny S. Subcutaneous implantable cardioverter-defibrillator and the two-incision intermuscular technique in pediatric patients - A single center experience. Kardiol Pol. 2021 Sep 30;79(9):1025–7. DOI: https://doi.org/10.33963/KP.a2021.0081
Teixeira RA, Fagundes AA, Junior JMB, de Oliveira JC, de Tarso Jorge Medeiros P, Valdigem BP, et al. Brazilian Guidelines for Cardiac Implantable Electronic Devices – 2023. Arq Bras Cardiol. 2023;120(1).
Song MK, Uhm JS, Baek JS, Yoon JK, Na JY, Yu HT, et al. Clinical outcomes of implantable cardioverter-defibrillator in pediatric patients - A Korean multicenter study. Circulation Journal. 2021;85(8):1356–64. DOI: https://doi.org/10.1253/circj.CJ-20-0468
Olde Nordkamp LRA, Postema PG, Knops RE, van Dijk N, Limpens J, Wilde AAM, et al. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications. Heart Rhythm. 2016 Feb;13(2):443–54. (https://pubmed.ncbi.nlm.nih.gov/26385533/) DOI: https://doi.org/10.1016/j.hrthm.2015.09.010
Vehmeijer JT, Brouwer TF, Limpens J, Knops RE, Bouma BJ, Mulder BJM, et al. Implantable cardioverter-defibrillators in adults with congenital heart disease: A systematic review and meta-analysis. Eur Heart J. 2016 May 7;37(18):1439–48. (https://pubmed.ncbi.nlm.nih.gov/26873095/) DOI: https://doi.org/10.1093/eurheartj/ehv735
Medeiros P, Santos M, Arantes C, Pereira VH, Rocha S. Implantable cardioverter-defibrillator in patients with inherited arrhythmia syndromes: A systematic review. Heart & Lung. 2023 Jul;60:1–7. (https://pubmed.ncbi.nlm.nih.gov/36863123/) DOI: https://doi.org/10.1016/j.hrtlng.2023.02.012
Roston TM, Jones K, Hawkins NM, Bos JM, Schwartz PJ, Perry F, et al. Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review. Heart Rhythm. 2018 Dec;15(12):1791–9. (https://pubmed.ncbi.nlm.nih.gov/30063211/) DOI: https://doi.org/10.1016/j.hrthm.2018.06.046
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Revista Multidisciplinar do Nordeste Mineiro
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
